MolecuLight Inc.: FDA 510(k) Clearance Expands Labelling of MolecuLight i:X to Include the Ability to Identify Regions Containing Elevated Load and More Bacterial Species
New FDA Clearance Illustrates the Utility of the i:X to Reliably DetectClinically Significant Bacteria that Impedes Wound Healing TORONTO, June 29, 2022 /PRNewswire/ -- MolecuLight Inc.
Source: finanznachrichten.de